Role of blood flow in carotid body chemoreflex function in heart failure

Journal of Physiology

Volumn 589, Issue 1, 2011, Pages 245-258

  Ding, Yanfeng ^a,b,c   Li, Yu Long ^a   Schultz, Harold D ^a,d  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; LOSARTAN; MICROSPHERE; N ACETYL S NITROSOPENICILLAMINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; POTASSIUM ION;

ADRENERGIC STIMULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY FLOW; CAROTID ARTERY OBSTRUCTION; CAROTID BODY CHEMORECEPTOR; CHEMORECEPTOR REFLEX; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HEART FAILURE; MALE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SENSORY NERVE CONDUCTION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD FLOW VELOCITY; CARDIAC PACING, ARTIFICIAL; CAROTID ARTERIES; CAROTID BODY; CHEMORECEPTOR CELLS; CONSTRICTION; DISEASE MODELS, ANIMAL; HEART FAILURE; KIDNEY; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE I; POTASSIUM; RABBITS; RECEPTOR, ANGIOTENSIN, TYPE 1; REFLEX; REGIONAL BLOOD FLOW; SPECTROMETRY, FLUORESCENCE; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 78650404479     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.200584     Document Type: Article

References (45)

1. Allen AM (1998). Angiotensin AT1 receptor-mediated excitation of rat carotid body chemoreceptor afferent activity. J Physiol 510, 773-781.
2. Barnett S, Mulligan E, Wagerle LC & Lahiri S (1988). Measurement of carotid body blood flow in cats by use of radioactive microspheres. J Appl Physiol 65, 2484-2489.
3. Biscoe TJ, Bradley GW & Purves MJ (1970). The relation between carotid body chemorecptor discharge, carotid sinus pressure and carotid body venous flow. J Physiol 208, 99-120.
4. Choi BR, Kim JS, Yang YJ, Park KM, Lee CW, Kim YH, Hong MK, Song JK, Park SW, Park SJ & Kim JJ (2006). Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 97, 1365-1369.
5. Chua TP, Ponikowski P, Webb-Peploe K, Harrington D, Anker SD, Piepoli M & Coats AJ (1997). Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex. Eur Heart J 18, 480-486.
6. Chugh SS, Chua TP & Coats AJS (1996). Peripheral chemoreflex in chronic heart failure: Friend and foe. Am Heart J 132, 900-904.
7. Ding Y, Li YL & Schultz HD (2008). Downregulation of carbon monoxide as well as nitric oxide contributes to peripheral chemoreflex hypersensitivity in heart failure rabbits. J Appl Physiol 105, 14-23.
8. Ding Y, Li YL, Zimmerman MC, Davisson RL & Schultz HD (2009). Role of CuZn superoxide dismutase on carotid body function in heart failure rabbits. Cardiovasc Res 81, 678-685.
9. Ding Y, Li YL, Zimmerman MC & Schultz HD (2010). Elevated mitochondrial superoxide contributes to enhanced chemoreflex in heart failure rabbits. Am J Physiol Regul Integr Comp Physiol 298, R303-R311.
10. Esler M, Kaye D, Lambert G, Esler D & Jennings G (1997). Adrenergic nervous system in heart failure. Am J Cardiol 80, 7L-14L.
11. Eyzaguirre C & Fidone SJ (1980). Transduction mechanisms in carotid body: glomus cells, putative neurotransmitters, and nerve endings. Am J Physiol Cell Physiol 239, C135-C152.
12. Fitzgerald RS, Eyzaguirre C & Zapata P (2009). Fifty years of progress in carotid body physiology - invited article. Adv Exp Med Biol 648, 19-28.
13. Floras JS (1993). Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 22, 72A-84A.
14. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E & Yusuf S (1990). Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82, 1724-1749.
15. Francis GS (1989). The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure. Am Heart J 118, 642-648.
16. Gao L, Wang W, Liu D & Zucker IH (2007). Exercise training normalizes sympathetic outflow by central antioxidant mechanisms in rabbits with pacing-induced chronic heart failure. Circulation 115, 3095-3102.
17. Krombach RS, Clair MJ, Hendrick JW, Houck WV, Zellner JL, Kribbs SB, Whitebread S, Mukherjee R, de Gasparo M, & Spinale FG (1998). Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns. Cardiovasc Res 38, 631-645.
18. Kumar P (2007). Sensing hypoxia in the carotid body: from stimulus to response. Essays Biochem 43, 43-60.
19. 2 flow in peripheral chemoreceptor excitation. Fed Proc 39, 2648-2652.
20. Lam SY & Leung PS (2002). A locally generated angiotensin system in rat carotid body. Regul Pept 107, 97-103.
21. Leimbach WN Jr, Wallin BG, Victor RG, Aylward PE, Sundlof G & Mark AL (1986). Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73, 913-919.
22. Li YL, Ding Y, Agnew C & Schultz HD (2008). Exercise training improves peripheral chemoreflex function in heart failure rabbits. J Appl Physiol 105, 782-790.
23. Li YL, Gao L, Zucker IH & Schultz HD (2007). NADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbits. Cardiovasc Res 75, 546-554.
24. Li YL, Li YF, Liu D, Cornish KG, Patel KP, Zucker IH, Channon KM & Schultz HD (2005). Gene transfer of neuronal nitric oxide synthase to carotid body reverses enhanced chemoreceptor function in heart failure rabbits. Circ Res 97, 260-267.
25. Li YL & Schultz HD (2006). Enhanced sensitivity of Kv channels to hypoxia in the rabbit carotid body in heart failure: role of angiotensin II. J Physiol 575, 215-227.
26. Li YL & Schultz HD (2007). Role of NADPH oxidase-derived superoxide anion on angiotensin II-enhanced sensitivity of potassium channels to hypoxia in carotid body of congestive heart failure rabbits. FASEB J 21, A1268.
27. Li YL, Sun SY, Overholt JL, Prabhakar NR, Rozanski GJ, Zucker IH & Schultz HD (2004). Attenuated outward potassium currents in carotid body glomus cells of heart failure rabbit: involvement of nitric oxide. J Physiol 555, 219-229.
28. Li YL, Xia XH, Zheng H, Gao L, Li YF, Liu D, Patel KP, Wang W & Schultz HD (2006). Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. Cardiovasc Res 71, 129-138.
29. 2+-activated potassium currents. J Neurophysiol 103, 3027-3033.
30. López-Barneo J, Ortega-Sáenz P, Pardal R, Pascual A, Piruat JI, Durán R & Gómez-Díaz R (2009). Oxygen sensing in the carotid body. Ann N Y Acad Sci 1177, 119-131.
31. Mark AL (1995). Sympathetic dysregulation in heart failure: mechanisms and therapy. Clin Cardiol 18, I3-I8.
32. McCloskey DI & Torrance RW (1971). Autoregulation of blood flow in the carotid body. Respir Physiol 13, 23-35.
33. Nurse CA (2010). Neurotransmitter and neuromodulatory mechanisms at peripheral arterial chemoreceptors. Exp Physiol 95, 657-667.
34. Prabhakar NR (2000). Oxygen sensing by the carotid body chemoreceptors. J Appl Physiol 88, 2287-2295.
35. Rajagopalan B, Raine AE, Cooper R & Ledingham JG (1984). Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment. Am J Med 76, 86-90.
36. Roig E, Perez-Villa F, Morales M, Jimenez W, Orus J, Heras M & Sanz G (2000). Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure. Eur Heart J 21, 53-57.
37. Schultz HD & Li YL (2007). Carotid body function in heart failure. Respir Physiol Neurobiol 157, 171-185.
38. Seymour AA, Burkett DE, Asaad MM, Lanoce VM, Clemons AF & Rogers WL (1994). Hemodynamic, renal, and hormonal effects of rapid ventricular pacing in conscious dogs. Lab Anim Sci 44, 443-452.
39. Spinale FG, Tanaka R, Crawford FA & Zile MR (1992). Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation 85, 717-729.
40. Sun SY, Wang W, Zucker IH & Schultz HD (1999a). Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J Appl Physiol 86, 1273-1282.
41. Sun SY, Wang W, Zucker IH & Schultz HD (1999b). Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. J Appl Physiol 86, 1264-1272.
42. Thein E, Raab S, Harris AG, Kleen M, Habler O, Meisner F & Messmer K (2002). Comparison of regional blood flow values measured by radioactive and fluorescent microspheres. Eur Surg Res 34, 215-223.
43. van de Wal RMA, Plokker HWM, Lok DJA, Boomsma F, Van Der Horst FAL, van Veldhuisen DJ, van Gilst WH & Voors AA (2006). Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. Int J Cardiol 106, 367-372.
44. Wanless RB, Anand IS, Gurden J, Harris P & Poole-Wilson PA (1987). Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: effects of isosorbide dinitrate, dobutamine and captopril. J Pharmacol Exp Ther 243, 1101-1106.
45. Zucker IH, Wang W, Brandle M, Schultz HD & Patel KP (1995). Neural regulation of sympathetic nerve activity in heart failure. Prog Cardiovasc Dis 37, 397-414.